Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Access the exclusive and authoritative pharma industry reports that only Pharma Intelligence can deliver. Encompassing a vast array of topics and disease areas, these exhaustive resources bring you the best in pharma sector reporting.
83 Total results for product and free and sample content found
Scrip
18 Dec 2019
Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.
In Vivo
18 Dec 2019
Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.
Pink Sheet
20 Nov 2019
Novartis finds itself facing possible criminal or civil action for admitted data manipulation on its application for Zolgensma, a gene therapy used to treat children with spinal muscular atrophy (SMA) – manipulation disclosed only after FDA approval. Pink Sheet was the first to report on the drug’s loss of EU accelerated assessment, nearly 3 weeks before the pharma giant admitted to submitting falsified data to FDA. Follow the scandal and anticipate its implications on the industry with Pink Sheet’s coverage and timeline.
Topic Cell and gene therapy FDA
Meddevicetracker
06 Nov 2019
Capture details about the worldwide market for COPD and asthma inhalation drug devices with Meddevicetracker’s “Drug Delivery: Inhalation Devices Report Extract: US, 5EU Markets, and Japan”.
Generics Bulletin
04 Nov 2019
As the push to promote the uptake of biosimilars in the US gains more momentum, new opportunities and challenges arise. Keep in tune with important developments in this impactful area using market coverage from Generics Bulletin.
Topic Biosimilars
Pharma Consulting
04 Nov 2019
You’ve probably noticed that biosimilars are the growth engine in global medicine spending right now. You’re not alone. With biologics accounting for 20-22% of total pharmaceutical spending already and looking to grow to $320 bn in the US alone by 2023, more and more companies and looking to compete in this arena. Informa’s Biosimilars Insights and Analysis Service can bring you the market intelligence and insights to inform your decisions and help ensure you’re not missing out on opportunities.
Topic Biosimilars
Biomedtracker, Datamonitor Healthcare
31 Oct 2019
Tap into insights and highlights from ESMO’s annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry.
Medtech Insight
25 Oct 2019
Stay aware of key developments and trends in US Medicare and understand their impact on the medtech industry with Medtech Insight. This article pack contains the latest US Medicare updates and late-stage developments.
Topic Medtech
Medtech Insight
25 Oct 2019
Don’t miss a beat with updated coverage of what’s happening with medtech and the US CMS with this article pack. Medtech Insight delivers vital, current news and insights.
Topic Medtech Policy and regulation
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
